Home » Newsletters » BioWorld

BioWorld

Nov. 13, 2001

View Archived Issues

BioMarin Attempts Offering Following Phase III Results

Gilead Compound Improves Liver Function, Reduces HBV Levels

Palatin Raises $11M Privately To Advance Development Efforts

Other News To Note

Fluidigm Raises $34M In Series C To Fund Microfluidics Programs

High-Oxygen Lab Environment Converts Muscle Fiber Into Fat As Stem Cells Flinch At Gases

ViroPharma, Wyeth-Ayerst Miss Mark In Phase II Hepatitis C Trial

Awaiting FDA Word, Amgen Offers Load Of Kineret News